An increase in opening of BKCa channels in smooth muscle cells in streptozotocin-induced diabetic mice

Acta Pharmacologica Sinica

Volumn 25, Issue 6, 2004, Pages 744-750

  Ye, Chun Ling ^a   Shen, Bing ^c   Ren, Xian Da ^a   Luo, Rong Jing ^b   Ding, Sheng Yuan ^b   Yan, Fu Man ^b   Jiang, Jia Hua ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Aorta; Calcium; Diabetes mellitus; Patch clamp techniques; Potassium channels; Streptozotocin

Indexed keywords

ACETYLCHOLINE; CALCIUM ACTIVATED POTASSIUM CHANNEL; COLLAGENASE; STREPTOZOCIN; TETRYLAMMONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CONDUCTANCE; CELL ISOLATION; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; MALE; MOUSE; MUSCLE TONE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; CELL SEPARATION; DIABETES MELLITUS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; TETRAETHYLAMMONIUM;

EID: 2942600224     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117-45.
2. Kaur J, Singh P, Sowers JR. Diabetes and cardiovascular diseases. Am J Ther 2002; 9: 510-5.
3. Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 2001; 21: 28-38.
4. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268 (4 Pt 1): C799-822.
5. Jackson WF. Potassium channels and regulation of the microcirculation. Microcirculation 1998; 5: 85-90.
6. Langton PD, Nelson MT, Huang Y, Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol 1991; 260 (3 Pt 2): H927-34.
7. Ikenaga H, Bast JP, Fallet RW, Carmines PK. Exaggerated impact of ATP-sensitive K(+) channels on afferent arteriolar diameter in diabetes mellitus. J Am Soc Nephrol 2000; 11: 1199-207.
8. + channel openers in cerebral arteries from diabetic rats. Circ Res 1997; 81: 996-1004.
9. Shen B, Ye CL, Ye KH, Liu JJ, Sun P, Jiang JH. Mechanism underlying enhanced endothelium-dependent vasodilatation in thoracic aorta of early stage streptozotocin-induced diabetic mice. Acta Pharmacol Sin 2003; 24: 422-8.
10. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415-7.
11. Ca channels: relation to Kv channels and nitric oxide. Br J Pharmacol 1999; 128: 637-46.
12. Ca channel in vascular muscle membranes of human saphenous veins. J Cardiovasc Pharmacol 1996; 28: 611-7.
13. Hammes HP. Pathophysiological mechanisms of diabetic angiopathy. J Diabetes Complications 2003; 17 (2 Suppl): 16-9.
14. Yorek MA. Role of oxidative stress in diabetic vascular and neural disease. Free Radic Res 2003; 37: 471-80.
15. Tare M, Parkington HC, Coleman HA. EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries. Br J Pharmacol 2000; 130: 605-18.
16. Misurski DA, Gopalakrishnan V. Role of calcium-activated potassium channels in impaired acetylcholine vasodilatory responses in diabetic rats. J Cardiovasc Pharmacol 2002; 39: 685-94.